Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In conclusion, the hypermethylation of RASSF1A or RUNX3 gene is therefore a useful biomarker to predict the prognosis in NSCLC, particularly RASSF1A due to SCCs and RUNX3 due to ACs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP274856.RA6gnYOKIS46Obvgdjfy60Dj40jm6djhl8s7rovJhrits130_assertion description "[In conclusion, the hypermethylation of RASSF1A or RUNX3 gene is therefore a useful biomarker to predict the prognosis in NSCLC, particularly RASSF1A due to SCCs and RUNX3 due to ACs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP274856.RA6gnYOKIS46Obvgdjfy60Dj40jm6djhl8s7rovJhrits130_provenance.
• assertion description "[In conclusion, the hypermethylation of RASSF1A or RUNX3 gene is therefore a useful biomarker to predict the prognosis in NSCLC, particularly RASSF1A due to SCCs and RUNX3 due to ACs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In conclusion, the hypermethylation of RASSF1A or RUNX3 gene is therefore a useful biomarker to predict the prognosis in NSCLC, particularly RASSF1A due to SCCs and RUNX3 due to ACs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In conclusion, the hypermethylation of RASSF1A or RUNX3 gene is therefore a useful biomarker to predict the prognosis in NSCLC, particularly RASSF1A due to SCCs and RUNX3 due to ACs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP285823.RAfxCx8kLZlXY5AM_zxBSPKRXTzd9SmihL6WvcPYFlT0o130_assertion description "[In conclusion, the hypermethylation of RASSF1A or RUNX3 gene is therefore a useful biomarker to predict the prognosis in NSCLC, particularly RASSF1A due to SCCs and RUNX3 due to ACs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP285823.RAfxCx8kLZlXY5AM_zxBSPKRXTzd9SmihL6WvcPYFlT0o130_provenance.
• NP861730.RATGLOiv5h4J90ZySc7hJZQDjuVcZrT4BCRDN9Qlhv9zg130_assertion description "[In conclusion, the hypermethylation of RASSF1A or RUNX3 gene is therefore a useful biomarker to predict the prognosis in NSCLC, particularly RASSF1A due to SCCs and RUNX3 due to ACs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP861730.RATGLOiv5h4J90ZySc7hJZQDjuVcZrT4BCRDN9Qlhv9zg130_provenance.
• assertion description "[In conclusion, the hypermethylation of RASSF1A or RUNX3 gene is therefore a useful biomarker to predict the prognosis in NSCLC, particularly RASSF1A due to SCCs and RUNX3 due to ACs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In conclusion, the hypermethylation of RASSF1A or RUNX3 gene is therefore a useful biomarker to predict the prognosis in NSCLC, particularly RASSF1A due to SCCs and RUNX3 due to ACs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In conclusion, the hypermethylation of RASSF1A or RUNX3 gene is therefore a useful biomarker to predict the prognosis in NSCLC, particularly RASSF1A due to SCCs and RUNX3 due to ACs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP861629.RAqlxfwM9R7BJA_UcAg-hM6jPkbI2PMhiCkw4lvwq1Qd4130_assertion description "[In conclusion, the hypermethylation of RASSF1A or RUNX3 gene is therefore a useful biomarker to predict the prognosis in NSCLC, particularly RASSF1A due to SCCs and RUNX3 due to ACs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP861629.RAqlxfwM9R7BJA_UcAg-hM6jPkbI2PMhiCkw4lvwq1Qd4130_provenance.
• NP618091.RAWrwFcntpAW73v3ppSwPpYkKGZvIJqemREAmDllssl9o130_assertion description "[In conclusion, the hypermethylation of RASSF1A or RUNX3 gene is therefore a useful biomarker to predict the prognosis in NSCLC, particularly RASSF1A due to SCCs and RUNX3 due to ACs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618091.RAWrwFcntpAW73v3ppSwPpYkKGZvIJqemREAmDllssl9o130_provenance.
• NP618093.RAfwVmnSr_aoyDhLkJQPAIfkNK8w8rjW5jki3N8Ud5Gbk130_assertion description "[In conclusion, the hypermethylation of RASSF1A or RUNX3 gene is therefore a useful biomarker to predict the prognosis in NSCLC, particularly RASSF1A due to SCCs and RUNX3 due to ACs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618093.RAfwVmnSr_aoyDhLkJQPAIfkNK8w8rjW5jki3N8Ud5Gbk130_provenance.
• NP618092.RACvH331yzGpUpfXcpdhPRqreK8u_HbHhRTm6GV0zNl_o130_assertion description "[In conclusion, the hypermethylation of RASSF1A or RUNX3 gene is therefore a useful biomarker to predict the prognosis in NSCLC, particularly RASSF1A due to SCCs and RUNX3 due to ACs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618092.RACvH331yzGpUpfXcpdhPRqreK8u_HbHhRTm6GV0zNl_o130_provenance.
• NP618096.RAvZXWs2QEu7c5pfuyc8ZJ1YHkDDf-qkB7p4fZRB6Tfjk130_assertion description "[In conclusion, the hypermethylation of RASSF1A or RUNX3 gene is therefore a useful biomarker to predict the prognosis in NSCLC, particularly RASSF1A due to SCCs and RUNX3 due to ACs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618096.RAvZXWs2QEu7c5pfuyc8ZJ1YHkDDf-qkB7p4fZRB6Tfjk130_provenance.
• NP285756.RA8i7HXg5o8Y5ex8KnbtGVG1mMgiGcrOqyb5As17OAJtk130_assertion description "[In conclusion, the hypermethylation of RASSF1A or RUNX3 gene is therefore a useful biomarker to predict the prognosis in NSCLC, particularly RASSF1A due to SCCs and RUNX3 due to ACs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP285756.RA8i7HXg5o8Y5ex8KnbtGVG1mMgiGcrOqyb5As17OAJtk130_provenance.
• NP285819.RAGjcuprx2kdMURPVk5k97vBt_0X7MFC_9VOjugQkQK6E130_assertion description "[In conclusion, the hypermethylation of RASSF1A or RUNX3 gene is therefore a useful biomarker to predict the prognosis in NSCLC, particularly RASSF1A due to SCCs and RUNX3 due to ACs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP285819.RAGjcuprx2kdMURPVk5k97vBt_0X7MFC_9VOjugQkQK6E130_provenance.
• NP618090.RAPTmMXoDGUcGkqcEU6XimPKR1VsRaWZ3vmfTOII5HjgI130_assertion description "[In conclusion, the hypermethylation of RASSF1A or RUNX3 gene is therefore a useful biomarker to predict the prognosis in NSCLC, particularly RASSF1A due to SCCs and RUNX3 due to ACs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618090.RAPTmMXoDGUcGkqcEU6XimPKR1VsRaWZ3vmfTOII5HjgI130_provenance.
• NP618098.RA0pJKEcdZZf72xuBoaM1iYx_VQXW0bIbNHsTfGuxxOH4130_assertion description "[In conclusion, the hypermethylation of RASSF1A or RUNX3 gene is therefore a useful biomarker to predict the prognosis in NSCLC, particularly RASSF1A due to SCCs and RUNX3 due to ACs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618098.RA0pJKEcdZZf72xuBoaM1iYx_VQXW0bIbNHsTfGuxxOH4130_provenance.